NCT00860782

Brief Summary

Children with sickle cell disease (SCD) are at risk for central nervous system (CNS) complications, which may affect academic achievement. This study will evaluate an educational support program for parents that aims to improve academic achievement in children with SCD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 10, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 12, 2009

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

August 2, 2021

Status Verified

July 1, 2021

Enrollment Period

7.8 years

First QC Date

March 10, 2009

Last Update Submit

July 26, 2021

Conditions

Keywords

Sickle Cell DiseaseEducational OutcomesNeurodevelopmental Functioning

Outcome Measures

Primary Outcomes (1)

  • Academic achievement as measured by the Woodcock Johnson Tests of Achievement, Third Edition

    Performance on standardized measure of academic achievement, M=100, SD=15

    Measured at baseline and Years 2 and 3

Secondary Outcomes (1)

  • Child's emotional and behavioral functioning, parental stress, and family functioning

    Measured at baseline and Years 2 and 3

Study Arms (2)

Annual Parent Intervention (API) Group

EXPERIMENTAL

Participants in this group will receive the parent educational support intervention once a year for 2 years.

Behavioral: Parent Educational Support

Quarterly Parent Intervention (QPI) Group

EXPERIMENTAL

Participants in this group will receive the parent educational support intervention quarterly (4 times a year) for 2 years.

Behavioral: Parent Educational Support

Interventions

Parents will attend 45-minute educational sessions that will focus on providing them with information regarding SCD and how they can best help their child perform better in school.

Annual Parent Intervention (API) GroupQuarterly Parent Intervention (QPI) Group

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children with either HbSS (sickle cell anemia) or HbSβ-thal (hemoglobin S beta thalassemia) who are between 6 and 12 years of age
  • Child's parent or primary caregiver agrees to participate in the study

You may not qualify if:

  • Child is monolingual in a language other than English and cannot complete standardized testing in English
  • Parent or caregiver of the child is not fluent in English or Spanish
  • Child has some other developmental disability not related to SCD. This would include Down's syndrome, autism, pervasive developmental disability, cerebral palsy, seizure disorder, consequences of severe prematurity, or a documented closed head injury that resulted in loss of consciousness.
  • Child has been diagnosed with a significant mental health disorder that is not responsive to behavioral or medical management. This includes severe depression, schizophrenia, or bipolar disorder. Children whose mental health problem is effectively treated are eligible for participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mailman Center for Child Development

Miami, Florida, 33131, United States

Location

MeSH Terms

Conditions

Hemoglobin SC DiseaseAnemia, Sickle Cell

Condition Hierarchy (Ancestors)

Anemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Daniel Armstrong, PhD

    University of Miami

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

March 10, 2009

First Posted

March 12, 2009

Study Start

August 1, 2008

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

August 2, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Following final data analysis and dissemination, the SAP and ICF will be shared with investigators requesting these materials.

Locations